In order to reduce the incidence of severe neonatal hyperbilirubinemia affecting newborns with jaundice in the USA and to prevent kernicterus, there is a need to implement proven prevention strategies for severe neonatal hyperbilirubinemia, as initiated by 2004 American Academy of Pediatrics Guidelines to all newborns in the USA.[1,102] The highest priority should be given to:
Designating TB greater than 427 μmol/l (>25 mg per 100 ml extreme hyperbilirubinemia) as a reportable condition through public health mandates;
These efforts should monitored by a kernicterus Electronic Disease Notification Data System in order to critically improve the timeliness and completeness of notifications and for allowing evaluation and interventions at the policy and individual family level.
Vinod K. Bhutani, Professor of Pediatrics-Neonatology Stanford University School of Medicine, Lucile Packard Children's Hospital, 750 Welch Rd, #315, Stanford, CA 94305, USA. firstname.lastname@example.org
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.
Pediatr Health. 2009;3(4):369-379. © 2009 Future Medicine Ltd.
Cite this: Screening for Severe Neonatal Hyperbilirubinemia - Medscape - Aug 01, 2009.